American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$416M |
| 2 |
PepsiCo
PEP
|
+$370M |
| 3 |
Aptiv
APTV
|
+$289M |
| 4 |
Johnson & Johnson
JNJ
|
+$283M |
| 5 |
NXP Semiconductors
NXPI
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$339M |
| 2 |
INXN
Interxion Holding N.V.
INXN
|
+$320M |
| 3 |
Apple
AAPL
|
+$239M |
| 4 |
Booz Allen Hamilton
BAH
|
+$236M |
| 5 |
Roper Technologies
ROP
|
+$220M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.12% |
| 2 | Financials | 16.35% |
| 3 | Healthcare | 15.09% |
| 4 | Consumer Discretionary | 11.64% |
| 5 | Industrials | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Coherent
COHR
$69.6B
| $25.8M | 0.02% |
765,190
+394,262
| +106% | +$12.6M |
|
452
Red Robin
RRGB
$151M
| $25.6M | 0.02% |
774,718
+293,077
| +61% | +$8.65M |
|
|
AMED
453
DELISTED
Amedisys
AMED
| $25.5M | 0.02% |
152,916
-136,665
| -47% | -$20.3M |
|
454
Gaotu Techedu
GOTU
$410M
| $25.1M | 0.02% |
1,146,014
+537,332
| +88% | +$9.14M |
|
455
Neurocrine Biosciences
NBIX
$15.9B
| $25M | 0.02% |
233,023
+6,854
| +3% | +$718K |
|
456
Deluxe
DLX
$1.09B
| $24.8M | 0.02% |
496,613
+38,733
| +8% | +$1.93M |
|
457
Chemed
CHE
$7.07B
| $24.7M | 0.02% |
56,249
+40,008
| +246% | +$16.8M |
|
458
Korn Ferry
KFY
$4.28B
| $24.6M | 0.02% |
579,973
+126,271
| +28% | +$4.88M |
|
459
Valero Energy
VLO
$95.1B
| $24.5M | 0.02% |
262,058
+244,021
| +1,353% | +$23.1M |
|
460
Humana
HUM
$46.7B
| $24.4M | 0.02% |
66,631
+61,158
| +1,117% | +$19.4M |
|
|
DOO
461
Bombardier Recreational Products
DOO
$4.69B
| $24.4M | 0.02% |
+535,606
| New | +$23.9M |
|
462
Nomad Foods
NOMD
$1.59B
| $24.4M | 0.02% |
1,089,238
-207,885
| -16% | -$4.23M |
|
|
DOC
463
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $24.3M | 0.02% |
1,281,829
+497,394
| +63% | +$9.12M |
|
464
Amdocs
DOX
$6.08B
| $24.2M | 0.02% |
335,592
-48,385
| -13% | -$3.3M |
|
465
PagSeguro Digital
PAGS
$2.44B
| $24.1M | 0.02% |
704,191
-421,090
| -37% | -$15.2M |
|
466
America Movil
AMX
$69.7B
| $23.9M | 0.02% |
1,492,434
+55,114
| +4% | +$862K |
|
467
Enovis
ENOV
$1.42B
| $23.8M | 0.02% |
380,063
+62,540
| +20% | +$3.54M |
|
468
AngloGold Ashanti
AU
$49.5B
| $23.8M | 0.02% |
1,065,215
-91,554
| -8% | -$1.84M |
|
469
White Mountains Insurance
WTM
$5.06B
| $23.7M | 0.02% |
21,288
+7,244
| +52% | +$7.9M |
|
470
Moody's
MCO
$82.8B
| $23.7M | 0.02% |
+99,956
| New | +$22.2M |
|
|
TPTX
471
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $23.7M | 0.02% |
380,660
+67,079
| +21% | +$3.19M |
|
|
IPG
472
DELISTED
Interpublic Group of Companies
IPG
| $23.7M | 0.02% |
1,025,271
+8,234
| +0.8% | +$181K |
|
473
Allegion
ALLE
$14.1B
| $23.7M | 0.02% |
189,976
-133,780
| -41% | -$15.4M |
|
474
HEICO Corp
HEI
$52.1B
| $23.6M | 0.02% |
207,087
-145,967
| -41% | -$18M |
|
475
Ralph Lauren
RL
$23.6B
| $23.6M | 0.02% |
201,587
-120,845
| -37% | -$12.7M |
|
Similar funds
American Century Companies's Q4 2019 Portfolio in Review
As of Q4 2019, American Century Companies held 1,608 positions worth $105B, up 5.4% from $99.6B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
American Century Companies's Q4 2019 filing shows 405 new, 473 increased, 604 reduced and 116 closed positions. Its largest new stake was NXP Semiconductors: 2,360,390 shares worth $300M. The largest sale was iShares Russell 1000 Value ETF, an estimated $339M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q4 2019 buy was NXP Semiconductors: 2,360,390 shares worth $300M.
- American Century Companies added most to Texas Instruments in Q4 2019, an estimated $416M increase.
- American Century Companies's biggest Q4 2019 reduction was iShares Russell 1000 Value ETF, cutting an estimated $339M.
- American Century Companies fully exited Celgene Corp in Q4 2019, selling an estimated $127M.
- American Century Companies's ten largest holdings make up 19% of its $105B portfolio in Q4 2019.
- American Century Companies opened 405 new positions and closed 116 in Q4 2019.
- American Century Companies's portfolio value rose 5.4% quarter-over-quarter to $105B.
Based on American Century Companies's 13F filing for Q4 2019, filed 12 Feb 2020.